Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SHC2 |
| Upstream (Parents) |
|---|
| (<<) SHMT1 → SHC2 |
| (<<) SLC4A4 → SHC2 |
| (<<) C19orf66 → SHC2 |
| (<<) BTD → SHC2 |
| Downstream (Children) |
|---|
| SHC2 → LHPP (>>) |
| SHC2 → SIGIRR (>>) |
| SHC2 → NXF3 (>>) |
| SHC2 → KLRF1 (>>) |
| SHC2 → CYP17A1 (>>) |
| SHC2 → PITX2 (>>) |
| SHC2 → CNTN5 (>>) |
| SHC2 → AZU1 (>>) |
| SHC2 → OXT (>>) |
| SHC2 → LIME1 (>>) |
| SHC2 → DICER1 (>>) |
| SHC2 → TAS2R14 (>>) |
| SHC2 → CRY2 (>>) |
| SHC2 → CLCN7 (>>) |
| SHC2 → PDE11A (>>) |
| SHC2 → BTD (>>) |
| SHC2 → RASSF9 (>>) |
| SHC2 → ATAD5 (>>) |
